![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.00 | 13.00 | 35.00 | 24.00 | 24.00 | 24.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.59 | 35.84M |
RNS Number:6007L Cambridge Antibody Tech Group PLC 2 June 2000 Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: John Aston 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: as in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): As in 2 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Allocation of pro-rata entitlement pursuant to open offer to shareholders 7 Number of shares/amount of stock acquired: 362 8 Percentage of issued class: 0.0011% 9 Number of shares/amount of stock disposed: 10 Percentage of issued class: 11 Class of security: 10p ordinary shares 12 Price per share: 1850p 13 Date of transaction: 10 April 2000 14 Date company informed: 10 April 2000 15 Total holding following this notification: 2,489 16 Total percentage holding of issued class following this notification: 0.0073% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263 233 25 Name of company official responsible for making notification: Diane Mellett Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Peter Garland 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: as in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): as in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): as in 2 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Allocation of pro-rata entitlement pursuant to open offer to shareholders 7 Number of shares/amount of stock acquired: 270 8 Percentage of issued class: 0.0008% 9 Number of shares/amount of stock disposed: 10 Percentage of issued class: 11 Class of security: 10p ordinary shares 12 Price per share: 1850p 13 Date of transaction: 10 April 2000 14 Date company informed: 10 April 2000 15 Total holding following this notification: 82,006 16 Total percentage holding of issued class following this notification: 0.24% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Diane Mellett Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Uwe Bicker 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: as in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): as in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): As in 2 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Allocation of pro-rata entitlement pursuant to open offer to shareholders 7 Number of shares/amount of stock acquired: 246 8 Percentage of issued class: 0.0007% 9 Number of shares/amount of stock disposed: 10 Percentage of issued class: 11 Class of security: 10p ordinary shares 12 Price per share: 1850p 13 Date of transaction: 10 April 2000 14 Date company informed: 10 April 2000 15 Total holding following this notification: 1,988 16 Total percentage holding of issued class following this notification: 0.0058% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Diane Mellett Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: Paul Nicholson 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: as in 2 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): as in 2 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): As in 2 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Allocation of pro-rata entitlement pursuant to open offer to shareholders 7 Number of shares/amount of stock acquired: 529 8 Percentage of issued class: 0.0015% 9 Number of shares/amount of stock disposed: 10 Percentage of issued class: 11 Class of security: 10p ordinary shares 12 Price per share: 1850p 13 Date of transaction: 10 April 2000 14 Date company informed: 10 April 2000 15 Total holding following this notification: 4,271 16 Total percentage holding of issued class following this notification: 0.012% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Diane Mellett Schedule 11 - Notification of interests of Directors and Connected Persons 1 Name of company: Cambridge Antibody Technology 2 Name of director: John Stocker 3 Please state whether notification indicates that it is in respect of holding of the director named in 2 above or holding of that person's spouse or children under the age of 18 or in respect of a non- beneficial interest: As in 2 above 4 Name of registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified): As in 2 above 5 Please state whether notification relates to a person(s) connected with the director named in 2 above and identify the connected person(s): As in 2 6 Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary: Allocation of pro-rata entitlement pursuant to open offer to shareholders 7 Number of shares/amount of stock acquired: 387 8 Percentage of issued class: 0.0011% 9 Number of shares/amount of stock disposed: 10 Percentage of issued class: 11 Class of security: 10p ordinary shares 12 Price per share: 1850p 13 Date of transaction: 10 April 2000 14 Date company informed: 10 April 2000 15 Total holding following this notification: 3,129 16 Total percentage holding of issued class following this notification: 0.0091% If a director has been granted options by the company, please complete the following fields: 17 Date of grant: 18 Period during which or date on which exercisable: 19 Total amount paid (if any) for grant of the option: 20 Description of shares or debentures involved: class, number: 21 Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise: 22 Total number of shares or debentures over which options held following this notification: 23 Contact name for queries: Diane Mellett 24 Contact telephone number: 01763 263233 25 Name of company official responsible for making notification: Diane Mellett END RDSEAFKAEEDEEFE
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions